Accretropin™ (somatropin) is indicated for:
- treatment of pediatric patients who have growth failure due to an inadequate secretion of normal endogenous growth hormone.
- treatment of short stature associated with Turner Syndrome in pediatric patients whose epiphyses are not closed.
ليست هناك تعليقات:
إرسال تعليق